Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study

J Aldred; A Amelin; A Antonini; B Bergmans; F Bergquist; M Bouchard; K Budur; C Carroll; K Chaudhuri; S Criswell; E Danielsen; EF Alvarez; F Gandor; J Jia; T Kimber; H Mochizuki; W Robieson; A Spiegel; D Standaert; S Talapala; M Facheris; V Fung

doi:10.1111/ene.15465

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study

J Aldred
, A Amelin
, A Antonini
, B Bergmans
, F Bergquist
, M Bouchard
, K Budur
, C Carroll
, K Chaudhuri
, S Criswell
, E Danielsen
, EF Alvarez
, F Gandor
, J Jia
, T Kimber
, H Mochizuki
, W Robieson
, A Spiegel
, D Standaert
, S Talapala

M Facheris, V Fung

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1111/ene.15465
Publication status	Published - Jul 2022

Access to Document

10.1111/ene.15465

Cite this

Aldred, J., Amelin, A., Antonini, A., Bergmans, B., Bergquist, F., Bouchard, M., Budur, K., Carroll, C., Chaudhuri, K., Criswell, S., Danielsen, E., Alvarez, EF., Gandor, F., Jia, J., Kimber, T., Mochizuki, H., Robieson, W., Spiegel, A., Standaert, D., ... Fung, V. (2022). Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study. https://doi.org/10.1111/ene.15465

@conference{5c8578325008408fa0eea25e6ef9f5d6,

title = "Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study",

author = "J Aldred and A Amelin and A Antonini and B Bergmans and F Bergquist and M Bouchard and K Budur and C Carroll and K Chaudhuri and S Criswell and E Danielsen and EF Alvarez and F Gandor and J Jia and T Kimber and H Mochizuki and W Robieson and A Spiegel and D Standaert and S Talapala and M Facheris and V Fung",

year = "2022",

month = jul,

doi = "10.1111/ene.15465",

language = "English",

}

Aldred, J, Amelin, A, Antonini, A, Bergmans, B, Bergquist, F, Bouchard, M, Budur, K, Carroll, C, Chaudhuri, K, Criswell, S, Danielsen, E, Alvarez, EF, Gandor, F, Jia, J, Kimber, T, Mochizuki, H, Robieson, W, Spiegel, A, Standaert, D, Talapala, S, Facheris, M & Fung, V 2022, 'Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study'. https://doi.org/10.1111/ene.15465

TY - CONF

T1 - Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study

AU - Aldred, J

AU - Amelin, A

AU - Antonini, A

AU - Bergmans, B

AU - Bergquist, F

AU - Bouchard, M

AU - Budur, K

AU - Carroll, C

AU - Chaudhuri, K

AU - Criswell, S

AU - Danielsen, E

AU - Alvarez, EF

AU - Gandor, F

AU - Jia, J

AU - Kimber, T

AU - Mochizuki, H

AU - Robieson, W

AU - Spiegel, A

AU - Standaert, D

AU - Talapala, S

AU - Facheris, M

AU - Fung, V

PY - 2022/7

Y1 - 2022/7

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000815254001012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

U2 - 10.1111/ene.15465

DO - 10.1111/ene.15465

M3 - Conference paper (not formally published)

ER -

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study

Access to Document

Other files and links

Cite this